Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Overview of attention for article published in Health technology assessment : HTA / NHS R & D HTA Programme., April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 270 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 19 X posts from 15 X users, with an upper bound of 68,407 followers.

@markcpetrie20 We did conduct a pilot study in prediabetes but main trial not funded https://t.co/yTEY0phKxm

28 Nov 2020

Reply Repost Favourite

@DanielJDrucker @Maratosflier @JimJohnsonSci @MMindrumMD @Dr__Guess @kevinnbass @NigelKinbrum @janvyjidak @jlevallois Any idea how this study is progressing? The feasibility study was published last year https://t.co/x9QfEDMYO6 but I can't tell if the actu

24 Jan 2019

Reply Repost Favourite

"It is unknown whether or not metformin can reduce the risk of these outcomes in people with elevated blood glucose levels BELOW the threshold for diabetes [i.e. non-diabetic hyperglycaemia (NDH)]." #inflammation https://t.co/MQ255qef0a

05 Sep 2018

Reply Repost Favourite

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. #NIHR HTA. https://t.co/wkxKK4TVJg https://t.co/UdKtxBaBOk

09 Jul 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.